Tech investors take a Warren Buffett approach to raising money for blood cancer research

Tech investors take a Warren Buffett approach to raising money for blood cancer research

Venture capitalist David Lee was diagnosed with Hodgkin’s lymphoma 24 years ago when he was a graduate Student at Stanford. Rhett Krawitt’s acute lymphoblastic leukemia was discovered eight years ago when he was just a toddler. Both are now cancer-free. Lee has a thriving investment career in Los Angeles and Krawitt is a Bay Area […]

Learn More
In the next few weeks, you can spend time with any one of these VCs and it will all go to charity

In the next few weeks, you can spend time with any one of these VCs and it will all go to charity

Five years ago, we told you about a venture capital auction wherein dozens of VCs donated their time toward a greater good — helping fund research at the Leukemia & Lymphoma Society, one of the world’s largest voluntary health organizations dedicated to funding research and access to treatments for blood cancer patients. The auction was […]

Learn More
Here’s the Problem with Today’s Human Clinical Trials

Here’s the Problem with Today’s Human Clinical Trials

LAGUNA NIGUEL, Calif.—The cost to develop and gain FDA approval for a new drug today is more than $2.5 billion, according to the Tufts Center for the Study of Drug Development. Driving much of that cost are human clinical trials. They’re necessary, from a regulatory standpoint as well as an intellectual one. And of course […]

Learn More
×